The Immune Reset: CAR T-Cell Therapy Offers a Potential Cure for Severe Lupus
A pioneering NHS trial successfully utilizes genetically modified T-cells to drive severe, treatment-resistant lupus into remission, signaling a paradigm shift…
Author: Marcus Chen
Based in Singapore, Marcus Chen specializes in the rapidly evolving fields of genomics, CRISPR technologies, and personalized diagnostics. With a background in bioinformatics and science journalism, he explores how genetic insights are transforming patient care and reshaping the diagnostic landscape. His investigative pieces often highlight the intersection of big data, AI, and next-generation sequencing in modern medicine.
The Fiber Buffer: Rethinking Diet and Metabolic Health Through the Microbiome
New research highlights how specific dietary fibers and prebiotics can stabilize glucose, combat fatty liver, and outperform extreme dietary restrictions.…
Pharma’s $106 Billion Summer: The Bolt-On Strategy to Beat the Patent Cliff
How a surge in targeted mid-sized acquisitions is reshaping oncology and metabolic pipelines as major drugmakers brace for a revenue…